Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.15
0.25 (1.94%)
At close: Aug 15, 2025, 3:59 PM
13.20
0.38%
After-hours: Aug 15, 2025, 05:41 PM EDT

Ginkgo Bioworks Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
49.6M 48.32M 43.85M 89.05M 56.21M 37.94M 34.76M 55.43M 80.57M 80.7M 98.28M 66.4M 144.62M 168.41M 148.49M 77.61M 43.64M 44.1M
Cost of Revenue
9.44M 12.05M 9.62M 9.99M 13.72M 22.07M 15.95M 6.92M 18.1M 22.38M 30.22M 24.66M 63.91M 85.43M 66.58M 22.3M 17.11M 23.7M
Gross Profit
40.16M 36.27M 34.23M 79.06M 42.48M 15.87M 18.81M 48.51M 62.47M 58.33M 68.07M 41.74M 80.71M 82.97M 81.92M 55.31M 26.53M 20.4M
Operating Income
-65.54M -88.97M -103.61M -55.2M -222.94M -158.74M -154.45M -286.39M -184.15M -215.75M -234.51M -653.02M -646.91M -674.51M -1.68B -26.67M -59.95M -57.12M
Interest Income
6.08M 6.08M 7.34M 9.25M 10.31M 11.71M 13.3M 15.02M 14.35M 14.54M 13.06M 5.82M 2.26M 177K 496K 121K n/a n/a
Pretax Income
-60.58M -90.87M -107.86M -56.78M -216.99M -165.88M -211.89M -302.91M -173.25M -204.89M -188.92M -669.08M -670.62M -592.78M -1.61B -102.61M -54.9M -74.94M
Net Income
-60.3M -90.96M -107.53M -56.4M -217.18M -165.91M -211.69M -302.89M -173.31M -204.97M -176.54M -670.13M -668.83M -590.5M -1.6B -101.88M -53.94M -73.57M
Selling & General & Admin
43.28M 49.04M 57.3M 52.29M 66.28M 51.02M 65.56M 82.03M 102.34M 111.43M 121.42M 435.18M 438.43M 434.77M 781.63M 28.96M 34.44M 17.93M
Research & Development
53.37M 70.92M 76.38M 77.01M 134.22M 123.59M 107.7M 156.66M 144.28M 162.64M 181.16M 259.58M 289.19M 322.72M 985.02M 53.02M 52.03M 59.59M
Other Expenses
9.05M 5.27M 4.16M 4.96M 64.92M n/a n/a 96.21M n/a n/a n/a -957K -51K 1.64M -1.62M n/a n/a n/a
Operating Expenses
105.7M 125.24M 137.83M 134.26M 265.43M 174.61M 173.26M 334.9M 246.62M 274.07M 302.57M 694.76M 727.62M 757.49M 1.77B 81.98M 86.47M 77.51M
Interest Expense
n/a n/a 94K n/a n/a n/a 93K n/a n/a n/a 13.06M 1.67M n/a 397K 551K 649K n/a 475K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -19.27M -23.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
115.14M 137.29M 147.45M 144.25M 279.15M 215.95M 212.87M 341.82M 264.72M 296.45M 332.79M 719.42M 791.53M 842.92M 1.83B 104.28M 103.58M 101.21M
Income Tax Expense
-283K 88K -325K -375K 190K 31K -198K -22K 67K 82K -14.77M -28K -45K -184K -683K -207K -431K -159K
Shares Outstanding (Basic)
54.86M 54.24M 51.89M 52.24M 51.33M 49.93M 49.11M 48.77M 48.14M 47.77M 45.6M 40.77M 40.52M 39.9M 36.94M 33.09M 32.31M 32.26M
Shares Outstanding (Diluted)
54.86M 54.24M 51.89M 52.25M 51.38M 49.99M 49.47M 48.77M 48.34M 47.92M 46.42M 40.77M 40.52M 40.19M 38.29M 33.09M 32.31M 32.26M
EPS (Basic)
-1.1 -1.68 -2.07 -1.08 -4.23 -3.32 -4.28 -6.21 -3.59 -4.28 -3.78 -16.44 -16.51 -14.69 -41.82 -3.08 -1.67 -2.28
EPS (Diluted)
-1.1 -1.68 -2.07 -1.08 -4.23 -3.32 -4.31 -6.21 -3.6 -4.29 -3.85 -16.44 -16.51 -14.8 -43.34 -3.08 -1.67 -2.28
EBITDA
-65.54M -68.33M -143.48M -35.09M -199.66M -165.13M -198.96M -169.12M -166.5M -196.79M -155.89M -646.02M -638.75M -666.43M -1.6B -17.79M -52.78M -51.49M
EBIT
-60.58M -87.98M -159.14M -52.26M -158.02M -178M -302.77M -190.18M -184.15M -215.75M -146.85M -654.94M -647.78M -675.37M -1.61B -26.67M -59.95M -57.12M
Depreciation & Amortization
15.79M 15.37M 15.65M 17.17M 17.33M 12.87M 12.84M 21.06M 25.94M 27M 33.03M 9.51M 9.61M 9.49M 8M 8.28M 7.17M 5.63M